CarmenElenaLandaverdeMD

PubMed

• 6 citations
  Ombitasvir/paritaprevir/ritonavir + dasabuvir +/- ribavirin in real world hepatitis C patients.
  Nicole Loo, Eric Lawitz, Naim Alkhouri, Jennifer Wells, Carmen Landaverde, Angie Coste, Rossalynn Salcido, Michael Scott, Fred Poordad> ;World Journal of Gastroenterology. 2019 May 14
• 45 citations
  Sofosbuvir-velpatasvir-voxilaprevir with or without ribavirin in direct-acting antiviral–experienced patients with genotype 1 hepatitis C virus
  Eric Lawitz, Fred Poordad, Jennifer Wells, Robert H. Hyland, Yin Yang, Hadas Dvory-Sobol, Luisa M. Stamm, Diana M. Brainard, John G. McHutchison, Carmen Landaverde, Ju...> ;Hepatology. 2017 Jun 1
• 63 citations
  Short‐duration treatment with elbasvir/grazoprevir and sofosbuvir for hepatitis C: A randomized trial
  Eric Lawitz, Fred Poordad, Julio A. Gutierrez, Jennifer Wells, Carmen Landaverde, Barbara Evans, Anita Y. M. Howe, H.-C. Huang, Jerry Jing Li, Peggy Hwang, Frank J. Du...> ;Hepatology. 2017 Feb 1
• 4 citations
  Lorcaserin Use in the Management of Morbid Obesity in a Pre-Liver Transplant Patient
  Julio A. Gutierrez, Carmen Landaverde, Jennifer Wells, Fred Poordad> ;Hepatology. 2016 Jul 1
• 3 citations
  Dual therapy of grazoprevir and elbasvir for the treatment of hepatitis C infection
  Carmen Landaverde, Jennifer Wells, Rebekah Hamner, Janie L Goldstein> ;Expert Review of Gastroenterology & Hepatology. 2016 Feb 24
• Treatment of patients with hepatitis C virus genotype 3: Where are we now?
  Carmen Landaverde, Jennifer T. Wells, Julio Gutierrez, Fred Poordad> ;Clinical Liver Disease. 2015 Oct 1
• 2 citations
  Management of patients with hepatitis C virus resistance-associated variants to NS5A inhibitors: Where are we now?
  Jennifer T. Wells, Carmen Landaverde, Julio A. Gutierrez, Eric Lawitz> ;Clinical Liver Disease. 2015 Oct 1
• 1 citations
  Prone positioning for transjugular intrahepatic portosystemic shunt revision to prevent exacerbation of existing radiation dermatitis.
  Bruce M. Bell, Angela Bruner, Carmen Landaverde, Chet R. Rees> ;Journal of Vascular and Interventional Radiology. 2015 May 1
• 40 citations
  Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome Clinical Implications and Treatment
  Robert S. Rahimi, Carmen Landaverde> ;Nutrition in Clinical Practice. 2013 Feb 1
• 23 citations
  Long-term follow-up of liver transplantation for Budd-Chiari syndrome with antithrombotic therapy based on the etiology.
  Srinath Chinnakotla, Goran B. Klintmalm, Peter T. W. Kim, Koji Tomiyama, E. Klintmalm, Gary L. Davis, James F. Trotter, Rana Saad, Carmen Landaverde, Marlon F. Levy, R...> ;Transplantation. 2011 Aug 15
• 70 citations
  Patients With NASH and Cryptogenic Cirrhosis Are Less Likely Than Those With Hepatitis C to Receive Liver Transplants
  Jacqueline G. O'Leary, Carmen Landaverde, Linda Jennings, Robert M. Goldstein, Gary L. Davis> ;Clinical Gastroenterology and Hepatology. 2011 Aug 1
• 19 citations
  Development of a disease-specific questionnaire to measure health-related quality of life in liver transplant recipients.
  Sammy Saab, Vivian Ng, Carmen Landaverde, Sung-Jae Lee, W. Scott Comulada, Jennifer Arevalo, Francisco Durazo, Steven-Huy B. Han, Zobari Younossi, Ronald W. Busuttil> ;Liver Transplantation. 2011 May 1
• 21 citations
  De-novo cholangiocarcinoma in native common bile duct remnant following OLT for primary sclerosing cholangitis
  Carmen Landaverde, Vivian Ng, Alisa Sato, James H. Tabibian, Francisco Durazo, Ronald W. Busuttil> ;Annals of Hepatology. 2009 Oct 1
• 3 citations
  Rapid virological response to peginterferon alfa and ribavirin treatment of chronic hepatitis C predicts sustained virological response and relapse in genotype 1 patie...
  Fred Poordad, Carmen Landaverde> ;Therapeutic Advances in Gastroenterology. 2009 Mar 1
• 4 citations
  Hepatocellular carcinoma in a hepatitis C patient with sustained viral response and no fibrosis.
  James H. Tabibian, Carmen Landaverde, Julie Winn, Stephen A. Geller, Nicholas N. Nissen> ;Annals of Hepatology. 2009 Jan 1
• 4 citations
  Deciding liver transplant candidacy: tools of the trade.
  Carmen Landaverde, Sammy Saab> ;Liver International. 2008 Oct 1
• 10 citations
  Intraductal oncocytic papillary neoplasm of the liver: Case and review of a rare variant
  James H. Tabibian, Charles Lassman, Daniel Margolis, Carmen Landaverde, Ronald W. Busuttil, Francisco Durazo> ;Annals of Hepatology. 2008 Apr 1
• 10 citations
  The MELD score in advanced liver disease: association with clinical portal hypertension and mortality.
  Sammy Saab, Carmen Landaverde, Ayman B. Ibrahim, Francisco Durazo, Steven Han, Douglas G. Farmer, R. Mark Ghobrial, Leonard I. Goldstein, Myron J. Tong, Ronald W. Busu...> ;Experimental and Clinical Transplantation. 2006 Jun 1
• 8 citations
  Retrasplante hepático: análisis de los resultados en 50 pacientes
  Carmen Landaverde, Marina Berenguer, Victoria Aguilera, Fernando San Juan, Martín Prieto, Joaquín Berenguer> ;The British and Foreign Medico-Chirurgical Review. 2005 May 21
• 34 citations
  Delayed onset of severe hepatitis C—Related liver damage following liver transplantation: A matter of concern?
  Marina Berenguer, Victoria Aguilera, Martín Prieto, Domingo Carrasco, Miguel Rayón, Fernando San Juan, Carmen Landaverde, José Mir, Joaquín Berenguer> ;Liver Transplantation. 2003 Nov 1
• 52 citations
  Fluid retention in cirrhosis: Pathophysiology and management
  Amir H. Kashani, C. Landaverde, Valentina Medici, Lorenzo Rossaro> ;QJM. 2008 Feb 1
• Join now to see all

Journal Articles

• Lorcaserin Use in the Management of Morbid Obesity in a Pre‐Liver Transplant Patient  
  Carmen Landaverde, MD, Hepatology